Spirovant Sciences – Potential of Gene Therapy in Targeting the Drivers of Cystic Fibrosis
Joan Lau, Ph.D., MBA, CEO of Spirovant Sciences discusses cystic fibrosis (CF) and how the standard of care right now addresses but does not correct the...
24 articles
Joan Lau, Ph.D., MBA, CEO of Spirovant Sciences discusses cystic fibrosis (CF) and how the standard of care right now addresses but does not correct the...
Lisa Yañez, CEO of Aerami Therapeutics, a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulm...
Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the Univ...
MeiLan Han, MD, MS, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan discusses chronic obstr...
Many service members who deployed to Iraq and Afghanistan following 9/11 are left struggling today with debilitating lung and respiratory conditions.
As a Broadway performer living with moderate-to-severe asthma, Tommy Bracco knows how difficult living with the disease can be. Tommy grew up singi...
Dr. Martin Kolb, Director of the Division of Respirology at the Department of Medicine at McMaster University and an expert on interstitial lung disease discusses...
MeiLan Han, MD MS, pulmonologist at the University of Michigan and author of the book "Breathing Lessons: a Doctor’s Guide to Lung Health" discusses t...
Jorge Gomez, MD, Medical Director, Thoracic Oncology Program and World Trade Center oncology clinic, Mount Sinai is here on behalf of Pfizer and the Ame...
Bruce Bender, PhD, lead researcher and co-director of the Center for Health Promotion at National Jewish Health discusses recent research published in "...